Racial and Ethnic Disparities in Take-Home Methadone Use for Medicare Beneficiaries With Opioid Use Disorder.
作者信息
Choi Sugy, Zhang Yutong, Unruh Mark Aaron, McGinty Emma E, Jung Hye-Young
机构信息
Department of Population Health, New York University Grossman School of Medicine, New York, New York.
Department of Population Health Sciences, Weill Cornell Medical College, New York, New York.
出版信息
JAMA Netw Open. 2024 Aug 1;7(8):e2431620. doi: 10.1001/jamanetworkopen.2024.31620.
Abstract
摘要
相似文献
1
Racial and Ethnic Disparities in Take-Home Methadone Use for Medicare Beneficiaries With Opioid Use Disorder.患有阿片类物质使用障碍的医疗保险受益人的美沙酮带回家使用情况中的种族和族裔差异。
JAMA Netw Open. 2024 Aug 1;7(8):e2431620. doi: 10.1001/jamanetworkopen.2024.31620.
2
Medicare Beneficiary Receipt of Methadone by Drive Time to Opioid Treatment Programs.按前往阿片类药物治疗项目的驾车时间划分的医疗保险受益者美沙酮接受情况。
JAMA Netw Open. 2025 Apr 1;8(4):e253099. doi: 10.1001/jamanetworkopen.2025.3099.
3
Variation in Opioid Agonist Dosing in Clinical Trials by Race and Ethnicity.种族和民族差异对阿片类激动剂在临床试验中的剂量的影响。
JAMA Netw Open. 2024 Oct 1;7(10):e2436612. doi: 10.1001/jamanetworkopen.2024.36612.
4
Assessment of Racial and Ethnic Disparities in the Use of Medication to Treat Opioid Use Disorder Among Pregnant Women in Massachusetts.评估马萨诸塞州孕妇使用药物治疗阿片类药物使用障碍的种族和民族差异。
JAMA Netw Open. 2020 May 1;3(5):e205734. doi: 10.1001/jamanetworkopen.2020.5734.
5
Medicare Payment for Opioid Treatment Programs.医疗保险对阿片类药物治疗计划的支付。
JAMA Health Forum. 2024 Jul 5;5(7):e241907. doi: 10.1001/jamahealthforum.2024.1907.
6
Changes In County-Level Access To Medications For Opioid Use Disorder After Medicare Coverage Of Methadone Treatment Began.医疗保险覆盖美沙酮治疗后，县一级阿片类药物使用障碍药物获取的变化。
Health Aff (Millwood). 2023 Jul;42(7):991-996. doi: 10.1377/hlthaff.2023.00148.
7
Trends in Methadone Dispensing for Opioid Use Disorder After Medicare Payment Policy Changes.医疗保险支付政策变化后美沙酮治疗阿片类药物使用障碍的趋势。
JAMA Netw Open. 2023 May 1;6(5):e2314328. doi: 10.1001/jamanetworkopen.2023.14328.
8
State sequence analysis of daily methadone dispensing trajectories among individuals at United States opioid treatment programs before and following COVID-19 onset.美国阿片类药物治疗项目中个体在新冠疫情爆发前后每日美沙酮配药轨迹的状态序列分析
Addiction. 2025 Jun;120(6):1207-1222. doi: 10.1111/add.70008. Epub 2025 Feb 26.
9
Introduction of Medicare coverage in opioid treatment programs: Findings from the first three years.阿片类药物治疗项目中医疗保险覆盖范围的引入：头三年的研究结果
J Subst Use Addict Treat. 2024 Mar;158:209247. doi: 10.1016/j.josat.2023.209247. Epub 2023 Dec 8.
10
Racial/ethnic disparities in timely receipt of buprenorphine among Medicare disability beneficiaries.医疗保险残疾受益人中丁丙诺啡及时获得情况的种族/民族差异。
Drug Alcohol Depend. 2023 Nov 1;252:110963. doi: 10.1016/j.drugalcdep.2023.110963. Epub 2023 Sep 14.
引用本文的文献
1
Medicaid Patients With ED Visits For Overdose: Disparities In Initiation Of Medications For Opioid Use Disorder.因过量用药而到急诊就诊的医疗补助计划患者：阿片类物质使用障碍药物治疗起始方面的差异
Health Aff (Millwood). 2025 May;44(5):622-630. doi: 10.1377/hlthaff.2024.00984.
本文引用的文献
1
Racial Inequality in Receipt of Medications for Opioid Use Disorder.种族不平等与阿片类药物使用障碍药物治疗的获得。
N Engl J Med. 2023 May 11;388(19):1779-1789. doi: 10.1056/NEJMsa2212412.
2
The impact of relaxation of methadone take-home protocols on treatment outcomes in the COVID-19 era.美沙酮居家服药方案放宽对 COVID-19 时代治疗效果的影响。
Am J Drug Alcohol Abuse. 2021 Nov 2;47(6):722-729. doi: 10.1080/00952990.2021.1979991. Epub 2021 Oct 20.
3
Racial/ethnic disparities in the use of medications for opioid use disorder (MOUD) and their effects on residential drug treatment outcomes in the US.美国在使用治疗阿片类药物使用障碍（MOUD）药物方面的种族/民族差异及其对住院药物治疗结果的影响。
Drug Alcohol Depend. 2021 Sep 1;226:108849. doi: 10.1016/j.drugalcdep.2021.108849. Epub 2021 Jun 24.
4
Validity of Race and Ethnicity Codes in Medicare Administrative Data Compared With Gold-standard Self-reported Race Collected During Routine Home Health Care Visits.医疗保险行政数据中种族和民族代码的有效性与常规家庭保健就诊期间收集的黄金标准自我报告种族进行比较。
Med Care. 2020 Jan;58(1):e1-e8. doi: 10.1097/MLR.0000000000001216.
Zotero 插件